Results 161 to 170 of about 480,923 (314)

Paramagnetic Rim Lesions Are Associated With Trans‐Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem   +17 more
wiley   +1 more source

Minutes: Strategic Enrollment Management Subcommitte, April 2, 2015

open access: yes, 2015
University of Minnesota Duluth. Strategic Enrollment Management Subcommitte. (2015). Minutes: Strategic Enrollment Management Subcommitte, April 2, 2015.
University of Minnesota Duluth. Strategic Enrollment Management Subcommitte
core  

Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock   +4 more
wiley   +1 more source

Minutes: Strategic Enrollment Management Subcommitte, November 20, 2015

open access: yes, 2015
University of Minnesota Duluth. Strategic Enrollment Management Subcommitte. (2015). Minutes: Strategic Enrollment Management Subcommitte, November 20, 2015.
University of Minnesota Duluth. Strategic Enrollment Management Subcommitte
core  

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

Strategic Management of Design and Conceptualization Factors for Wearable Postural Rehabilitation Devices: A Causal Interdependency Analysis. [PDF]

open access: yesBiomimetics (Basel)
Constantin A   +6 more
europepmc   +1 more source

Covid-19 shock: Development of strategic management framework for global energy. [PDF]

open access: yesRenew Sustain Energy Rev, 2021
Chofreh AG   +5 more
europepmc   +1 more source

Minutes: Strategic Enrollment Management Subcommitte, November 16, 2016

open access: yes, 2016
University of Minnesota Duluth. Strategic Enrollment Management Subcommitte. (2016). Minutes: Strategic Enrollment Management Subcommitte, November 16, 2016.
University of Minnesota Duluth. Strategic Enrollment Management Subcommitte
core  

Home - About - Disclaimer - Privacy